Upregulation of LncDQ is Associated with Poor Prognosis and Promotes Tumor Progression via Epigenetic Regulation of the EMT Pathway in HCC | Zendy

Bing Zeng | Zendy; Zewei Lin | Zendy; Huilin Ye | Zendy; Di Cheng | Zendy; Guangtao Zhang | Zendy; Jindu Zhou | Zendy; Zhifeng Huang | Zendy; Meng Wang | Zendy; Canfeng Cai | Zendy; Jun Zeng | Zendy; Chaoming Tang | Zendy; Jikui Liu | Zendy

Open Access

Upregulation of LncDQ is Associated with Poor Prognosis and Promotes Tumor Progression via Epigenetic Regulation of the EMT Pathway in HCC

Author(s) -

Bing Zeng,

Zewei Lin,

Huilin Ye,

Di Cheng,

Guangtao Zhang,

Jindu Zhou,

Zhifeng Huang,

Meng Wang,

Canfeng Cai,

Jun Zeng,

Chaoming Tang,

Jikui Liu

Publication year - 2018

Publication title -

cellular physiology and biochemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.486

H-Index - 87

eISSN - 1421-9778

pISSN - 1015-8987

DOI - 10.1159/000488841

Subject(s) - downregulation and upregulation , epigenetics , cancer research , medicine , tumor progression , microrna , cancer , biology , gene , genetics

Long noncoding RNAs (lncRNAs) are key regulators of cancer initiation and progression. In this study, we investigated the clinical value and functional role of LncRNA DQ786243 (LncDQ) in the pathogenesis of hepatocellular carcinoma (HCC).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research